Periprosthetic Joint Infection (PJI) is one of the greatest
challenges in orthopaedics. Despite technological advances in implant
design and surgical techniques, the overall incidence of PJI is
steadily increasing.1 Moreover, the occurrence of culture
negative infections, inflammatory conditions / other comorbidities,
and premature administration of antibiotics, all present obstacles to
the clinical diagnosis of PJI.
Zimmer Biomet is committed
to helping surgeons and infection specialists improve management of
PJI with the use of diagnostics.
Our proprietary synovial
fluid tests aim to facilitate diagnosis of PJI, by detecting unique
local biomarkers (or proteins), which measure the body’s specific
response to disease.